Matthew Abelman

Person

Mill Valley, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Substituted heterocyclic compounds
- Patent number 9,045,428
- Issue date Jun 2, 2015
- Gilead Sciences, Inc.
- Matthew Abelman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fused heterocyclic compounds as ion channel modulators
- Patent number 8,952,007
- Issue date Feb 10, 2015
- Gilead Sciences, Inc.
- Matthew Abelman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted heterocyclic compounds as ion channel modulators
- Patent number 8,865,739
- Issue date Oct 21, 2014
- Gilead Sciences, Inc.
- Matthew Abelman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted heterocyclic compounds
- Patent number 8,716,319
- Issue date May 6, 2014
- Gilead Sciences, Inc.
- Matthew Abelman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted heterocyclic compounds as ion channel modulators
- Patent number 8,664,399
- Issue date Mar 4, 2014
- Gilead Sciences, Inc.
- Matthew Abelman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused heterocyclic compounds as ion channel modulators
- Patent number 8,664,379
- Issue date Mar 4, 2014
- Gilead Sciences, Inc.
- Matthew Abelman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused heterocyclic compounds as ion channel modulators
- Patent number 8,389,500
- Issue date Mar 5, 2013
- Gilead Sciences, Inc.
- Matthew Abelman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
ALDH-2 inhibitors in the treatment of addiction
- Patent number 8,158,810
- Issue date Apr 17, 2012
- Gilead Sciences, Inc.
- Jeff Zablocki
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinazolinone derivatives as ALDH-2 inhibitors
- Patent number 7,951,813
- Issue date May 31, 2011
- Gilead Sciences, Inc.
- Matthew Abelman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
ABCA1 elevating compounds
- Patent number 7,432,276
- Issue date Oct 7, 2008
- CV Therapeutics, Inc.
- Matthew Abelman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
ABCA1 elevating compounds
- Patent number 7,423,045
- Issue date Sep 9, 2008
- CV Therapeutics, Inc.
- Matthew Abelman
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
SUBSTITUTED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS
- Publication number 20140107155
- Publication date Apr 17, 2014
- GILEAD SCIENCES, INC.
- Matthew Abelman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS
- Publication number 20140094460
- Publication date Apr 3, 2014
- GILEAD SCIENCES, INC.
- Matthew Abelman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED HETEROCYCLIC COMPOUNDS
- Publication number 20130324525
- Publication date Dec 5, 2013
- GILEAD SCIENCES, INC.
- Matthew Abelman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS
- Publication number 20130102632
- Publication date Apr 25, 2013
- GILEAD SCIENCES, INC.
- Matthew Abelman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS
- Publication number 20130096122
- Publication date Apr 18, 2013
- GILEAD SCIENCES, INC.
- Matthew Abelman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED HETEROCYCLIC COMPOUNDS
- Publication number 20100197684
- Publication date Aug 5, 2010
- Gilead Palo Alto, Inc.
- Matthew Abelman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS
- Publication number 20100125091
- Publication date May 20, 2010
- Gilead Palo Alto, Inc.
- Matthew Abelman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS
- Publication number 20100113449
- Publication date May 6, 2010
- Gilead Palo Alto, Inc.
- Matthew Abelman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS
- Publication number 20100113514
- Publication date May 6, 2010
- Gilead Palo Alto, Inc.
- Matthew Abelman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ALDH-2 INHIBITORS IN THE TREATMENT OF ADDICTION
- Publication number 20090209533
- Publication date Aug 20, 2009
- Jeff Zablocki
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED HETEROCYCLIC COMPOUNDS
- Publication number 20090181986
- Publication date Jul 16, 2009
- Matthew Abelman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED HETEROCYCLIC COMPOUNDS
- Publication number 20090012103
- Publication date Jan 8, 2009
- Matthew Abelman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ABCA1 ELEVATING COMPOUNDS
- Publication number 20080293757
- Publication date Nov 27, 2008
- Matthew Abelman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
QUINAZOLINONE DERIVATIVES AS ALDH-2 INHIBITORS
- Publication number 20080249116
- Publication date Oct 9, 2008
- Jeff Zablocki
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ALDH-2 INHIBITORS IN THE TREATMENT OF ADDICTION
- Publication number 20080207610
- Publication date Aug 28, 2008
- Jeff Zablocki
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ALDH-2 INHIBITORS IN THE TREATMENT OF DRUG ADDICTION
- Publication number 20080032995
- Publication date Feb 7, 2008
- Jeff Zablocki
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ABCA1 elevating compounds
- Publication number 20070191379
- Publication date Aug 16, 2007
- Matthew Abelman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ABCA1 elevating compounds
- Publication number 20070010544
- Publication date Jan 11, 2007
- Matthew Abelman
- C07 - ORGANIC CHEMISTRY

Matthew Abelman

Person

Patents Grantslast 30 patents

Substituted heterocyclic compounds

Fused heterocyclic compounds as ion channel modulators

Substituted heterocyclic compounds as ion channel modulators

Substituted heterocyclic compounds

Substituted heterocyclic compounds as ion channel modulators

Fused heterocyclic compounds as ion channel modulators

Fused heterocyclic compounds as ion channel modulators

ALDH-2 inhibitors in the treatment of addiction

Quinazolinone derivatives as ALDH-2 inhibitors

ABCA1 elevating compounds

ABCA1 elevating compounds

Patents Applicationslast 30 patents

SUBSTITUTED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS

FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS

SUBSTITUTED HETEROCYCLIC COMPOUNDS

SUBSTITUTED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS

FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS

SUBSTITUTED HETEROCYCLIC COMPOUNDS

SUBSTITUTED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS

FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS

FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS

ALDH-2 INHIBITORS IN THE TREATMENT OF ADDICTION

SUBSTITUTED HETEROCYCLIC COMPOUNDS

SUBSTITUTED HETEROCYCLIC COMPOUNDS

ABCA1 ELEVATING COMPOUNDS

QUINAZOLINONE DERIVATIVES AS ALDH-2 INHIBITORS

ALDH-2 INHIBITORS IN THE TREATMENT OF ADDICTION

ALDH-2 INHIBITORS IN THE TREATMENT OF DRUG ADDICTION

ABCA1 elevating compounds

ABCA1 elevating compounds